199 related articles for article (PubMed ID: 17505842)
1. Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system.
Okazaki T; Sakamuro D
J Cancer Res Clin Oncol; 2007 Sep; 133(9):581-8. PubMed ID: 17505842
[TBL] [Abstract][Full Text] [Related]
2. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
3. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
[TBL] [Abstract][Full Text] [Related]
4. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
[TBL] [Abstract][Full Text] [Related]
5. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
[TBL] [Abstract][Full Text] [Related]
6. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin induces Fas (APO-1/CD95)-dependent apoptosis of human tongue carcinoma cells: sensitization for apoptosis by upregulation of FADD expression.
Mishima K; Nariai Y; Yoshimura Y
Int J Cancer; 2003 Jul; 105(5):593-600. PubMed ID: 12740905
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for the Fas-/Fas-Ligand pathway in chemoresistance of human squamous cell carcinomas of the head and neck (SCCHN)?
Sproll KC; Balló H; Hoffmann TK; Scheckenbach K; Koldovsky U; Balz V; Hafner D; Ramp U; Bier H
Oral Oncol; 2009 Jan; 45(1):69-84. PubMed ID: 18620901
[TBL] [Abstract][Full Text] [Related]
9. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
[TBL] [Abstract][Full Text] [Related]
10. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
Villunger A; Egle A; Kos M; Hartmann BL; Geley S; Kofler R; Greil R
Cancer Res; 1997 Aug; 57(16):3331-4. PubMed ID: 9269989
[TBL] [Abstract][Full Text] [Related]
12. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.
Brás A; Albar JP; Leonardo E; de Buitrago GG; Martínez-A C
Cell Death Differ; 2000 Mar; 7(3):262-71. PubMed ID: 10745271
[TBL] [Abstract][Full Text] [Related]
13. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells.
Jiang S; Wu MW; Sternberg P; Jones DP
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):645-55. PubMed ID: 10711676
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cells.
Li Y; Mao Y; Rosal RV; Dinnen RD; Williams AC; Brandt-Rauf PW; Fine RL
Int J Cancer; 2005 May; 115(1):55-64. PubMed ID: 15645452
[TBL] [Abstract][Full Text] [Related]
15. p53 promotes selection for Fas-mediated apoptotic resistance.
Maecker HL; Koumenis C; Giaccia AJ
Cancer Res; 2000 Aug; 60(16):4638-44. PubMed ID: 10969818
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of reactive oxygen species (ROS) and resistance to Fas-mediated apoptosis in the C33A cervical cancer cell line transfected with IL-18 receptor.
Yoon- DY; Cho YS; Park JW; Kim SH; Kim JW
Clin Chem Lab Med; 2004 May; 42(5):499-506. PubMed ID: 15202785
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells.
Shao RG; Cao CX; Nieves-Neira W; Dimanche-Boitrel MT; Solary E; Pommier Y
Oncogene; 2001 Apr; 20(15):1852-9. PubMed ID: 11313933
[TBL] [Abstract][Full Text] [Related]
18. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expression in a Fas/FasL- and p53-independent manner.
Choi YJ; Ok DW; Kwon DN; Chung JI; Kim HC; Yeo SM; Kim T; Seo HG; Kim JH
FEBS Lett; 2004 Sep; 575(1-3):41-51. PubMed ID: 15388331
[TBL] [Abstract][Full Text] [Related]
19. c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Prostate; 2003 Jun; 55(4):265-80. PubMed ID: 12712406
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis.
Liu T; Laurell C; Selivanova G; Lundeberg J; Nilsson P; Wiman KG
Cell Death Differ; 2007 Mar; 14(3):411-21. PubMed ID: 16917513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
